Black Rock Inc. Fate Therapeutics Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Black Rock Inc. holds 10,116,106 shares of FATE stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,116,106

Previous 9,099,951 11.17%

Holding current value

$17 Million

Previous $66.8 Million 50.32%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.26 - $7.08 $3.31 Million - $7.19 Million	1,016,155 Added 11.17%	10,116,106 $33.2 Million
Q1 2024 May 10, 2024	SELL	$3.54 - $8.35 $7.48 Million - $17.6 Million	-2,112,865 Reduced 18.84%	9,099,951 $66.8 Million
Q4 2023 Feb 13, 2024	SELL	$1.65 - $3.94 $2.1 Million - $5.01 Million	-1,271,674 Reduced 10.19%	11,212,816 $41.9 Million
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $1.02 Million - $2.55 Million	505,932 Added 4.22%	12,484,490 $26.5 Million
Q2 2023 Aug 11, 2023	BUY	$4.76 - $6.59 $2.39 Million - $3.31 Million	502,315 Added 4.38%	11,978,558 $57 Million
Q1 2023 May 12, 2023	BUY	$4.24 - $11.12 $7.42 Million - $19.5 Million	1,750,019 Added 17.99%	11,476,243 $65.4 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $17.8 Million - $43.1 Million	1,808,803 Added 22.85%	9,726,224 $98.1 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $10.6 Million - $18.1 Million	501,445 Added 6.76%	7,917,421 $177 Million
Q2 2022 Aug 12, 2022	BUY	$17.78 - $42.39 $5.52 Million - $13.2 Million	310,305 Added 4.37%	7,415,976 $184 Million
Q1 2022 May 12, 2022	BUY	$29.67 - $60.28 $1.34 Million - $2.72 Million	45,119 Added 0.64%	7,105,671 $275 Million
Q4 2021 Feb 10, 2022	BUY	$47.84 - $64.34 $17.5 Million - $23.5 Million	365,006 Added 5.45%	7,060,552 $413 Million
Q3 2021 Nov 09, 2021	BUY	$59.27 - $95.73 $5.9 Million - $9.53 Million	99,586 Added 1.51%	6,695,546 $397 Million
Q2 2021 Aug 11, 2021	BUY	$67.25 - $92.52 $444 Million - $610 Million	6,595,960 New	6,595,960 $572 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $163M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account